Skip to main content
APD logo

APD · Air Products & Chemicals, Inc.

Track APD — free
$281.31 +2.12 (+0.76%)
Market Cap
$62.12B
Shares
222.69M
Volume · Sep 30 318.66K Avg daily vol (3M) 1.16M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$279.19 Open$277.75 Day$276.47–281.06 52W close$230.76–314.19 Avg vol 30d1.1M Short int4.1M · 1.8% float · 4.6d Short vol44% Last earningsJul 30, 2026 DataJan 2020–Sep 2026 Filing10-Q · Jul 30

Up next

Next earnings call
Oct 29, 2026 Est · unconfirmed · in 4 wks
filed Jul 30, 2026
call held Jul 30, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$12.60B
Trailing 12 months
Net income (TTM)
−$47.30M
Trailing 12 months
Revenue growth YoY
+4.6%
Year over year
Operating margin
-4.7%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-0.5%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
0.0%
Year over year · fewer shares
Price change (1Y)
+3.2%
Trailing year
Short interest
1.8%
Latest settlement · 4.6 days to cover
View all 115 metrics

AI Brief

Q3 FY26 earnings call · Jul 30, 2026
Q3 FY26

TL;DR. Air Products reported Q3 FY26 adjusted EPS of $3.47, up 12% and above guidance, driven by volume and equity affiliates; the company is raising full-year FY26 adjusted EPS guidance to $13.39–$13.49 (11–12% growth) and lowering FY26 capex to ~$3.5 billion, while exiting the Louisiana clean energy and Casa Grande projects with a $2.9 billion pre-tax charge.

Bullish
  • + Raised full-year FY26 adjusted EPS guidance to $13.39–$13.49, implying 11% to 12% growth.
  • + Traditional industrial gas backlog of ~$3 billion includes over $1.5 billion in electronics project wins in the last six months.
  • + FY26 capital expenditure outlook lowered to ~$3.5 billion, reflecting payment timing and cancelled projects.
Bearish
  • − Europe operating margin contracted 90 basis points (with ~50 bp energy cost pass-through headwind) on higher power costs and fixed-cost inflation.
  • − Americas operating income growth of 6% was partially offset by higher costs including fixed-cost inflation, increased distribution and dislocation costs, and project development costs.
  • − Management cited macroeconomic uncertainties in Asia and Europe and built in no significant market growth into forward outlook.
  • − Equity affiliate income surge in Middle East was largely contractual/timing-driven on a preferred dividend and will normalize in Q4.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Weak Sentiment Neutral Fundamentals Weak Quant / Vol Low
Market backdrop VIX 16 · calm Equity put/call 0.38
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −2%
below
Price vs 50-day avg −6%
below
RSI (14) 35
neutral
MACD trend Negative
52-week position 58%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Weak
1-month return −10%
trailing
6-month return −6%
trailing
YTD return +13%
this year
Relative strength −19%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $297 › 200d $285 — 50d above 200d
Institutional flow Distributing
-1% holders QoQ · +133 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.83% of float · ▲ +0.4% MoM · 4.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,787 holders — near 3-yr high, broad support
Squeeze score 45
elevated · 0–100
Fundamentals
Weak
Revenue growth −1%
Y/Y
Gross margin 25%
expanding
EPS growth −110%
Y/Y
Free cash flow $-5.3B
Buyback $485.3M
remaining
Balance sheet $15.8B
net debt
Quant / Vol
risk profile
Low
Volatility 26%
annualized · 1-yr
Max drawdown −15%
past year
ATR 2.0%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 4 of last 6
Latest guidance · from the 8-K filed Jul 30, 2026
full-year fiscal 2026
Adjusted EPS Non-GAAP Initiated $13.39 – $13.49
Capital expenditures Non-GAAP Initiated $3.5B
fiscal 2026 fourth quarter
Adjusted EPS Non-GAAP Initiated $3.55 – $3.65
Guided vs delivered · last 6 settled
Earnings per share fiscal year 2022
guided $10.20 – $10.40
$10.14 Miss −1.6%
Earnings per share quarter one of fiscal year '22
guided $2.45 – $2.55
$2.52 In line
EPS fiscal year 2021
guided $8.95 – $9.05
$9.43 Beat +4.8%
Earnings per share Quarter 3 of fiscal year 2021
guided $2.30 – $2.40
$2.40 In line

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
2 · 5 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−2% Neutral
Price vs 50-day avg
−6% Bearish
RSI (14)
35 Neutral
MACD trend
Negative Bearish
52-week position
58% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $297 › 200d $285 — 50d above 200d
Institutional flow Distributing
-1% holders QoQ · +133 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
1.83% of float · ▲ +0.4% MoM · 4.6 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
1,787 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $231 Now $279 · 58% Range high $314
vs 200-day avg -2% vs 50-day avg -6%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
APD
Air Products & Chemicals, Inc.
this stock
$62.12B +13.0% -0.5% — 1.8%
LIN
Linde PLC
$216.61B +11.0% +3.0% 30.3 1.3%
AIQUF
L Air Liquide SA /Fi
$121.25B +1.1% — — 0.0%
SHW
Sherwin Williams Co
$79.89B +2.0% +2.1% 30.4 2.6%
ECL
Ecolab Inc.
$78.35B +5.8% +2.2% 37.5 1.9%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
1,787
% held
92.7%
Net QoQ
+4.7M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
758
View
Short & Settlement
Short Interest Rising
Shares short
4.1M
Days to cover
4.6d
Change
+17.4K sh
View
Short Volume
Short vol %
44%
As of
Sep 29, 2026
Short Total
View
Fails to Deliver
FTD shares
188
Value
$57.4K
As of
Aug 28, 2026
View
Off-Exchange
Off-exchange %
43.1%
Week of
Aug 24, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Richard Dean McCormick
Amount
$1.0K–$15.0K
Traded
Jul 30, 2026
View
Financials
Financials
Revenue (FY)
$12.0B
Net income (FY)
$-394.5M
EPS diluted
$-1.77
View
Buybacks
Authorized
$1.0B
Remaining
$485.3M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Jul 30, 2026
This year
8
View
Proposed Sales
Value
$824.4K
Shares
2.7K
Filed
May 1, 2026
View
Earnings & Events
Earnings Calls
Last call
Jul 30, 2026
View

Performance

5D 20D 120D MTD YTD
APD -3.0% -9.8% -5.9% -9.8% +13.0%
SPY -1.2% -0.4% +13.1% -0.4% +12.1%
vs SPY -1.8% -9.4% -18.9% -9.4% +1.0%

Capital returns

Declared · upcoming
$1.81 / share · ex Oct 1, 2026
Paid (TTM)
$0.00 / share · 0 payouts
Dividend yield (TTM, derived)
— · no payout in the trailing year
Buyback program · as of Sep 30, 2025
Authorized
$1.00B
Spent (derived)
$514.70M
Remaining
$485.30M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 2969 CUSIP 009158106 13F (30d) 44 filings 24 filers Visit website Investor relations